Sammy Farah, Turnstone Biologics CEO
The pivot: Turnstone Biologics opens a new chapter with a switch to clinical development and a new venture round to pay for it
In biotech, most startups get about 5 years to get their preclinical act in order and jump into human studies before the backers get restive …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
